Las recientes reformas de los delitos contra la libertad e indemnidad sexuales

Abstract

Findings from this study question the need for multiple pre-treatment PRO assessments in oncology drug development trials and the degree of bias thought to be introduced through patient knowledge of treatment assignment. Implications for researchers are presented.